Although validation of our observations should be obtained in genetically modified mice (with LDL receptor or apolipoprotein E knockout, known to develop atherosclerosis), our findings clearly highlighted hyperlipidemia repression by PACs. This evidence concerns the gene APOE and hyperlipidemia.